Glenmark Pharmaceuticals LimitedNSE: GLENMARK

Press Release Oct 19 2020

· Issued by Glenmark Pharmaceuticals Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-oct-19-2020-5

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 19, 2020, titled "Glenmark Pharmaceuticals receives ANDA approval for Sirolimus Tablets, 0.5 mg, 1 mg and 2 mg".

View Attachment

6ix hasn’t read this filing yet.

Glenmark Pharmaceuticals Limited on 6ix

Earlier from Glenmark Pharmaceuticals

Later from Glenmark Pharmaceuticals

All Glenmark Pharmaceuticals news releases